NPI: 1710932090 · JACKSON, MS 39204 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/24/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/24/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,294 | $375K |
| 2019 | 20,769 | $369K |
| 2020 | 17,962 | $348K |
| 2021 | 16,797 | $332K |
| 2022 | 11,823 | $346K |
| 2023 | 6,361 | $416K |
| 2024 | 3,044 | $378K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 30,557 | 3,049 | $2.06M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 26,614 | 1,780 | $319K |
| A4657 | Syringe, with or without needle, each | 5,217 | 2,209 | $66K |
| 83970 | 1,724 | 1,509 | $47K | |
| J1756 | Injection, iron sucrose, 1 mg | 5,734 | 1,556 | $20K |
| 82728 | 1,161 | 1,045 | $11K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 17,074 | 1,701 | $9K |
| 83550 | 1,091 | 1,004 | $7K | |
| 83540 | 1,268 | 1,125 | $6K | |
| 85045 | 1,634 | 1,458 | $4K | |
| 85041 | 1,688 | 1,507 | $3K | |
| 85048 | 1,684 | 1,503 | $3K | |
| 82108 | 113 | 106 | $3K | |
| 90674 | 67 | 62 | $1K | |
| 87340 | 33 | 33 | $343.80 | |
| 82607 | 17 | 17 | $316.37 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 20 | 13 | $294.30 |
| 82746 | 15 | 15 | $231.60 | |
| 85046 | 24 | 24 | $150.65 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 900 | 611 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 85 | 74 | $0.00 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 330 | 161 | $0.00 |